CANF
Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares
CANF
CANF
10 hedge funds and large institutions have $710K invested in Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$190K | |
| 2 | +$112K | |
| 3 | +$42K | |
| 4 |
MC
Menta Capital
San Francisco,
California
|
+$27K |
| 5 |
Goldman Sachs
New York
|
+$23K |
Top Sellers
| 1 | -$841K | |
| 2 | -$296K | |
| 3 | -$5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| 5 |
Citigroup
New York
|
-$2K |